Adamas pharma posts q3 loss per share of $0.99

Adamas reports third quarter 2019 financial results.q3 loss per share $0.99.q3 earnings per share estimate $-0.89 -- refinitiv ibes data.q3 gocovri product sales of $13.9 million.topline results from inroads phase 3 study of ads-5102 are expected in second half of december 2019.

ADMS Ratings Summary

ADMS Quant Ranking